A promising advance to complement clinical diagnosis at an early stage of Alzheimer’s disease (AD) has been the measurement of biomarkers in cerebrospinal fluid (CSF).1 A decrease in CSF amyloid beta 42 (Ab42) is a marker of AD pathology caused by the accumulation of amyloid-b in brain parenchyma,2 whereas increased total tau (t-tau) and hyperphosphorylated tau (p-tau) reflect neuronal degeneration and tangle pathology.3 AD is characterized by episodic memory loss, cognitive impairment, behavioral disorders, and finally, dementia.4 Individuals with mild cognitive impairment (MCI) have memory defi- cits but, in contrast to those with AD, are functionally intact and at higher risk of converting to AD than those without MCI.4 It is difficult t...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Esta tesis profundiza en el conocimiento de las enfermedades neurodegenerativas y, concretamente, en...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...
Objective: This study aimed to investigate the role and prognosis of Alzheimer disease biomarkers in...
Objective: To describe the Amyloid, Tau, Neurodegeneration (A/T/N) research framework classification...
RESUMEN : Actualmente las demencias tienen un gran impacto social por ser causa de dependencia, d...
Introduction: The prodromal Alzheimer�Ls disease (AD) is a new concept that include an amnesic mild ...
Purpose: Argentina-Alzheimer’s Disease Neuroimaging Initiative (Arg-ADNI) is the first ADNI study to...
Introduction: The goals of this study were to compare the early diagnostic utility of Alzheimer dise...
Introduction: Some studies have shown that CSF amyloid-beta 1-42 (Aβ1-42), total tau (T-tau) and tau...
Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgent...
Systematic evaluation of biomarkers in representative populations is needed to validate their clinic...
salvador M guinjoan1,2 gustavo sevlever1 ricardo F allegri1,2 1instituto de investigaciones Neurológ...
Alzheimer’s disease (AD) is a slow and progressive neurodegenerative disorder.With new treatment str...
Esta tesis profundiza en el conocimiento de las enfermedades neurodegenerativas y, concretamente, en...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Esta tesis profundiza en el conocimiento de las enfermedades neurodegenerativas y, concretamente, en...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...
Objective: This study aimed to investigate the role and prognosis of Alzheimer disease biomarkers in...
Objective: To describe the Amyloid, Tau, Neurodegeneration (A/T/N) research framework classification...
RESUMEN : Actualmente las demencias tienen un gran impacto social por ser causa de dependencia, d...
Introduction: The prodromal Alzheimer�Ls disease (AD) is a new concept that include an amnesic mild ...
Purpose: Argentina-Alzheimer’s Disease Neuroimaging Initiative (Arg-ADNI) is the first ADNI study to...
Introduction: The goals of this study were to compare the early diagnostic utility of Alzheimer dise...
Introduction: Some studies have shown that CSF amyloid-beta 1-42 (Aβ1-42), total tau (T-tau) and tau...
Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgent...
Systematic evaluation of biomarkers in representative populations is needed to validate their clinic...
salvador M guinjoan1,2 gustavo sevlever1 ricardo F allegri1,2 1instituto de investigaciones Neurológ...
Alzheimer’s disease (AD) is a slow and progressive neurodegenerative disorder.With new treatment str...
Esta tesis profundiza en el conocimiento de las enfermedades neurodegenerativas y, concretamente, en...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Esta tesis profundiza en el conocimiento de las enfermedades neurodegenerativas y, concretamente, en...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...